Abstract:Objective To assay the gene expression and the serum protein level of vascular enˉdothelial growth factor(sVEGF),and study the relationship between VEGF and childhood acute leukemia.Methods41cases in different stages of childhood acute leukemia and5normal children were included.And the gene expressions of VEGF in the bone marrow were studied with real-time reverse transcriptase polyˉmerase chain reaction(RT-PCR).The expression of sVEGF in55children with acute leukemia and20normal children was also observed with sandwich enzyme-linked immunoabsorbent assay(ELISA).Results The expression of VEGF was found in90.5%(19/21)of the samples from newly diagnosed paˉtients,30.0%(6/20)of the samples from incomplete remission(CR)patients,but none of the normal chilˉdren.The positive percentage of the expression of VEGF gene between different stages of acute leukemia patients and CR patients was significantly different(P<0.001).The same results were also found between acute leukemia patients and normal control(P<0.001);with no difference between CR patients and normal control(P>0.05).The sVEGF levels in the newly diagnosed patients were significantly higher than that of patients in CR and normal control(both P<0.001);sVEGF level in the refractory or relapsed patients was much higher than that of pre-treatment patients,patients in CR and normal control(P<0.05,P<0.001,P<0.001);but no difference could be found between CR and normal patients(P>0.05).For the untreated patients,the sVEGF level was significantly correlated with:1)the duration of being CR(r=0.8030,P<0.01),2)the peripheral white blood cell count at the initial stage of the disease(r=0.7564,P<0.01),3)marrow involvement(P<0.05)and the level of serum lactate dehydrogenase(P<0.05).No correlation was found between sVEGF level and other clinic factors.Conclusions The gene expression of VEGF correlated closely with the pathogenesis of childhood acute leukemia and its prognosis indicating they may play an imˉportant role in the development of leukemia.The dynamic detection of VEGF gene expression and sVEGF level could be used as one of the risk factor and prognostic factor in childhood acute leukemia.

Quantitative Analysis of Gene Expression for Vascular Endothelial Growth Factor and Its Application.

Expression and role of vascular endothelial growth factor and its receptors in acute myeloid leukemia with normal cytogenetics

Profiling of Micrornas in Aml Cells Following Overexpression or Silencing of the Vegf Gene

[The Effect of on VEGF-C Cdna Transfection on NB4 Cell Proliferation, Differentiation and Resistance to Apoptosis].

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Genetic Inhibition Of Vascular Endothelial Growth Factor Receptor-1 Significantly Inhibits The Migration And Proliferation Of Leukemia Cells And Increases Their Sensitivity To Chemotherapy

Study on the role of vascular endothelial growth factor in the pathogenesis of childhood acute leukemia

[Effect of ATRA and DNR on the Expression and Secretion of VEGF in Leukemic Cells].

[Effect of VEGFR1 Gene Silencing by Shrna on Proliferation, Migration and Apoptosis of U937 Line].

Up-Regulation Of Vegf And Its Receptor In Refractory Leukemia Cells

Preliminary Study of VEGF and Its Receptor Expression on Childhood Acute Lymphoblastic Leukemia and Its Relativity to Clinical Manifestations

[Effect of Recombinant VEGF-C Secreted from Eukaryotic Cells on Proliferation and Chemotherapy-Induced Apoptosis of Leukemic Cells].

Application of SENP-1, HIF-1α and VEGF Gene Expressions in Prognostic Prediction for Normal Karyotypic Acute Leukemia Patients with NPM1 + and FLT3-ITD - .

Study on effect of vascular endothelial growth factor on acute myeloid leukemic cells in vitro

Experimental Study of Apoptosis in Leukemic Cell Lines Induced by Combined Use of Bevacizumab and Chemotherapeutic Drug

Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia]

Clinical Significance of Serum VEGF in Acute Leukemia in Children

[Change of Vascular Endothelial Growth Factor and Its Receptors Expression in Acute Myeloid Leukemia Before and after Treatment].

[Expression of Vascular Endothelial Growth Factor in the Bone Marrow Cells from Adult Chronic Myelogenous Leukemia]

[Expression of Angiogenic Factors and Their Clinical Significances in Acute Myeloid Leukemia].

Construction of VEGF Eukaryotic Expression Vector and Its Effects on Proliferation and Chemosensitivity in Leukemia Cells